Archive - February 2019
AZ’ RSV drug bags EMA PRIME, FDA Breakthrough statuses
Isatuximab shows positive results in Phase III trial for multiple myeloma
Sanofi’s Darzalex rival scores in myeloma trial
US, EU regulators back rapid reviews of AZ’s RSV med
Novo Nordisk preps for speedy oral GLP-1 drug filing
Boots to launch specialist pharmacist practitioner role
Polypharmacy reviews becoming ‘increasingly important’
Mapping of oesophageal cancer gene mutations leads to new drug targets
